stopOverflowHandler
Synthetic / Extracted Drugs
icone_health.png
Filter     Order     Display # 
Item Title
NOVEL NON ENZYMATIC INHIBITORS OF SYK TYROSINE KINASE
USE OF CHLORINE GUANABENZ DERIVATIVES FOR TREATING POLYGLUTAMINE EXPANSION ASSOCIATED DISEASES
NEW HETEROCYCLE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
URIC ACID INHIBITION PREVENTS LUNG INFLAMMATION AND FIBROSIS
USE OF ADENINE-DERIVED COMPOUNDS FOR THE TREATMENT OF LUPUS
CFTR CHANNEL MODULATORS
NEW MODULATORS OF THE HEDGEHOG SIGNALING PATHWAY: APPLICATIONS IN CANCER THERAPY
NOVEL MULTIMERIC CD40 LIGANDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR PREPARING DRUGS
IDENTIFICATION AND USE OF miRNAs FOR DIFFERENTIATING MYELOGENOUS LEUKAEMIA CELLS
NEW INDIRUBIN CLASS USEFUL FOR TREATING TUMORS WITH APOPTOSIS RESISTANCE MECANISMS
USE OF PURINE DERIVATIVES FOR THE PRODUCTION OF MEDICAMENTS FOR THE TREATMENT OF MUCOVISCIDOSIS AND DISEASES RELATED TO PROTEIN ADDRESSING ERRORS IN CELLS
USE OF ELECTRIC PULSES TO INTRODUCE ANTICANCER AGENTS INTO CANCER CELLS
NOVEL APOPTOGENIC AGENTS FOR THE TREATMENT OF CHEMORESISTANT CANCERS
TREATMENT FOR EATING DISORDERS: 5-HT4 RECEPTORS
4-(ARYLTHIO)-PYRIDIN-2(1H)-ONES: NEW DRUGS TO TREAT HIV DISEASES
PYRIDINONE AND PYRIDINETHIONE DERIVATIVES WITH HIV INHIBITING PROPERTIES
3-(AMINO- OR AMINOALKYL)PYRIDINONE DERIVATIVES: NEW DRUGS FOR THE TREATMENT OF HIV RELATED DISEASES
NOVEL CALCIUM RECEPTOR MOLECULES
NEW DIAMINES WITH CALCILYTIC ACTIVITIES ON THE CALCIUM SENSING RECEPTOR
ARTEMISININ DERIVATIVES IN THE TREATMENT OF MALARIA
PROTEIN AIF: APOPTOSIS INDUCING FACTOR
USE OF BENZO(C)QUINOLIZINIUM FOR THE CFTR CHLORIDE CHANNEL'S ACTIVATION
USE OF BENZO(C)QUINOLIZINIUM DERIVATIVES FOR THE TREATMENT OF DISEASES LINKED TO SMOOTH MUSCLE CELL CONSTRICTION
USE OF PAULLONE DERIVATIVES FOR THE PRODUCTION OF MEDICAMENTS FOR THE TREATMENT OF MUCOVISCIDOSIS AND DISEASES RELATED TO PROTEIN ADDRESSING ERRORS IN CELLS
IMPROVEMENT OF GENE TARGETING EFFICIENCY BY DNA CHEMICAL MODIFICATION
NOVEL PHARMACEUTICAL COMPOUNDS HAVING A GUANIDINE STRUCTURE
COMPOUNDS USEFUL AS MODULATORS OF THE PROTEASOME ACTIVITY
SULFOGLYCOLIPID ANTIGENS, THEIR EXTRACTION FROM MYCOBACTERIUM TUBERCULOSIS, AND THEIR USE AGAINST TUBERCULOSIS
ANTI-TUBULIN ACTING ARYLPYRROL, ARYLFULRAN AND ARYLTHIOPENE DERIVATIVES, METHOD FOR THE PREPARATION AND USE THEREOF AS AN ANTIMITOTIC
ANTI-CANCER PRODUCTS FOR TREATING CYSTIC FIBROSIS
 
<< Start < Prev 1 Next > End >>
Results 1 - 30 of 30
 
 

Identification






Please, give us your feedback
Ask Fist
Direct Access
+33 1 40 51 00 90
02/04/13 : FIST soutient le projet MATWIN

Ouverture du 5e appel à candidatures de MATWIN Programme national de sourcing et d’accompagnement à la ...
Details ...



17/01/13 : CNRS INNOVATION la lettre n°1  La première édition de CNRS INNOVATION la lettre est parue le 11 Janvier 2013 Lien Details ...



08/04/13 : CNRS atteint la 5ème place du classement INPI de 2012

Le CNRS atteint la 5ème place du classement INPI des premiers organismes et entrerpises déposants en 2012 ...
Details ...
 
   
viagra 100mg